Spastic Paraplegia Type 7
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Spastic Paraplegia Type 7

What is the definition of Spastic Paraplegia Type 7?

Spastic paraplegia type 7 (also called SPG7) is one of more than 80 genetic disorders known as hereditary spastic paraplegias. These disorders primarily affect the brain and spinal cord (central nervous system), specifically nerve cells (neurons) that extend down the spinal cord. These neurons are used for muscle movement and sensation. Signs and symptoms of hereditary spastic paraplegias are characterized by progressive muscle stiffness (spasticity) in the legs and difficulty walking.

What are the causes of Spastic Paraplegia Type 7?

Mutations in the SPG7 gene cause spastic paraplegia type 7. The SPG7 gene provides instructions for producing a protein called paraplegin. Located within the inner membrane of the energy-producing centers of cells (mitochondria), paraplegin is one of the proteins that form a complex called the m-AAA protease. The m-AAA protease acts as an enzyme and is responsible for assembling ribosomes (cellular structures that process the cell's genetic instructions to create proteins) and removing nonfunctional proteins in the mitochondria.

How prevalent is Spastic Paraplegia Type 7?

The prevalence of all hereditary spastic paraplegias combined is estimated to be 2 to 6 in 100,000 people worldwide. This group of conditions is the most common cause of inherited spasticity. Spastic paraplegia type 7 likely accounts for only a small percentage of all spastic paraplegia cases.

Is Spastic Paraplegia Type 7 an inherited disorder?

In most cases, spastic paraplegia type 7 is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Spastic Paraplegia Type 7 Local Doctors?
Elite in Spastic Paraplegia Type 7
Elite in Spastic Paraplegia Type 7
Referral may be required
Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 

Rebecca Schule practices practicing medicine in Tuebingen, Germany. Ms. Schule is rated as an Elite expert by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Spastic Paraplegia Type 7, Paraplegia, Spasticity, and Spastic Paraplegia Type 2.

Elite in Spastic Paraplegia Type 7
Elite in Spastic Paraplegia Type 7
Referral may be required

Erasmus MC

Rotterdam, ZH, NL 

Giovanni Stevanin practices practicing medicine in Rotterdam, Netherlands. Mr. Stevanin is rated as an Elite expert by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Paraplegia, Spasticity, and Acute Cerebellar Ataxia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Spastic Paraplegia Type 7
Elite in Spastic Paraplegia Type 7
Referral may be required
Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 

Ludger Schols practices practicing medicine in Tuebingen, Germany. Mr. Schols is rated as an Elite expert by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Paraplegia, Spastic Paraplegia Type 7, Spasticity, and Drug Induced Dyskinesia.

What are the latest Spastic Paraplegia Type 7 Clinical Trials?
TreatHSP/SPAX Master Protocol: Adaptive Platform for Longitudinal Progression, Biomarkers and Pathophysiology in Ataxias, Hereditary Spastic Paraplegias and Spastic Ataxias (TreatHSP/SPAX)

Summary: Ataxias, hereditary spastic paraplegias (HSP), and spastic ataxias (collectively referred to as SPAX diseases) are rare neurological conditions that cause progressive problems with walking, balance, coordination, and daily activities. Although many SPAX diseases are caused by specific genetic changes, there is still limited knowledge about how symptoms develop over time, how fast the diseases prog...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Noninvasive Spinal Cord Neuromodulation to Enhance Motor Function in Individuals With Hereditary Spastic Paraplegia

Summary: Hereditary spastic paraplegia (HSP) is a rare neurological condition that causes stiffness, weakness, and difficulty walking due to damage in the nerves that control movement. This study will test whether a noninvasive form of spinal cord stimulation, called transcutaneous spinal cord stimulation (tSCS), can improve walking and reduce muscle stiffness in adults with HSP. In this study, participant...

Who are the sources who wrote this article ?

Published Date: June 25, 2021
Published By: National Institutes of Health